Your Trusted Clinical Testing

We provide high-accuracy PCR testing for a range of infectious diseases, including:

• Respiratory infections (COVID-19, Flu, RSV, etc.)
• Urinary tract infections (UTIs)
• Sexually transmitted diseases (STDs)
• Gastrointestinal pathogens (GI)
• Pneumonia panel
• HPV screening

All tests are designed to offer rapid, accurate results with minimal disruption to patient care.

Test results are delivered within 24 hours of sample receipt. This allows for quick clinical decision-making, improving outcomes and reducing delays in treatment.

Our tests use real-time PCR technology, which offers:

• Higher sensitivity and specificity
• Faster results
• Ability to detect low pathogen levels that might be missed by culture or antigen testing

This leads to more accurate diagnoses and better treatment targeting.

In most cases, a provider’s order or prescription is required for testing, especially when billing insurance. This ensures the test is medically necessary and that results are interpreted in the proper clinical context.

However, if you prefer to pay out of pocket, we also accept self-pay patients without a prescription. This option is ideal for:

• Proactive screening
• Privacy-conscious individuals
• Patients without insurance or with high deductibles

Out-of-pocket testing is straightforward, and we’ll provide you with full results directly.

Yes. Most major insurance plans, including Medicare and Medicaid, cover our tests when they are medically necessary.

To qualify for insurance reimbursement, a provider’s prescription or order is required. This ensures proper clinical documentation and compliance with payer requirements.

Yes, we welcome out-of-pocket patients who wish to pay directly for testing — no insurance or prescription required. This option is ideal for:

• Individuals without insurance
• Patients with high deductibles or out-of-network plans
• Those seeking confidential or proactive screening

To schedule an out-of-pocket test:

• Call our office directly, or
• Use our online appointment system to choose a time that works for you

You'll receive fast, accurate results with the same level of care and service we provide to all patients.

Sample collection varies depending on the test:

• Nasopharyngeal swab for respiratory testing
• Urine sample for UTI and STD testing
• Stool swab for GI testing
• Sputum sample for pneumonia testing
• Cervical swab for HPV screening

All methods are designed to be as non-invasive and convenient as possible for both patients and staff.

Yes. Our panels are designed to detect multiple pathogens at once, helping providers:

• Pinpoint the exact cause of symptoms
• Identify co-infections
• Reduce the need for multiple tests or follow-ups

Absolutely. Our testing is highly suitable for pediatric, geriatric, and immunocompromised patients who need fast, accurate results to prevent complications and reduce unnecessary treatments.

We offer:

• Personalized logistics and reporting
• Custom integration with your clinical workflow
• Responsive customer service
• No-cost implementation — including supplies, shipping, and billing management

Our goal is to make high-quality testing seamless and stress-free for your team.

For healthcare providers or clinics:
Getting started is simple. Contact our team to:

• Schedule an onboarding call
• Set up your account and workflow
• Receive starter kits, supplies, and support

We’ll guide you through every step and tailor the setup to your practice’s needs.

For out-of-pocket patients:
No prescription is needed. You can:

• Give us a call to schedule a test
• Or use our online appointment system to book directly

We’ll take care of the rest and ensure your results are delivered promptly and confidentially.

The panel simultaneously detects:

• SARS-CoV-2 (COVID-19)
• Influenza A
• Influenza B
• Respiratory Syncytial Virus (RSV)

This ensures broad coverage of the most common respiratory viruses seen during cold and flu season.

Test results are typically returned within 24 hours of specimen collection. This rapid turnaround allows providers to make quick clinical decisions and initiate appropriate treatments.

A single nasopharyngeal swab is used to collect the sample, simplifying workflow and minimizing discomfort for the patient.

Unlike antigen tests, this is a molecular PCR test, which offers:

• Higher sensitivity
• Better accuracy
• Ability to detect low viral loads, even in early-stage or asymptomatic cases

This test is ideal for:

• Patients presenting with respiratory symptoms during cold and flu season
• Outbreak investigation in congregate settings
• High-risk populations (elderly, immunocompromised) where accurate detection is essential

Yes. Rapid, accurate identification of the virus helps providers:

• Prescribe antivirals promptly for influenza or COVID-19
• Avoid unnecessary antibiotic use
• Initiate appropriate isolation protocols

This test is appropriate for patients exhibiting respiratory symptoms, especially during cold and flu season. Common symptoms include:

• Fever or chills
• Cough
• Sore throat
• Shortness of breath
• Fatigue or body aches
• Runny nose or nasal congestion
• Loss of taste or smell (specific to COVID-19)
• Headache or gastrointestinal symptoms (in some cases)

Testing is also recommended when symptoms are mild, ambiguous, or overlapping, as PCR testing can help differentiate between similar viral illnesses like COVID-19, flu, and RSV.

We provide:

• All necessary supplies for testing
• Insurance billing
• Result tracking and reporting support

In most clinical settings, a healthcare provider’s order or prescription is required to perform this test. This ensures the test is medically indicated and helps with proper insurance documentation and clinical follow-up.

LabTurbo offers a distinct advantage with our:

• Faster turnaround times – Results are typically delivered within 24 hours, enabling same-day treatment decisions.
• Responsive, timely support – Our team is local and highly accessible, providing direct communication and real-time updates that large national labs often can’t match.
• Customizable service – We tailor logistics, reporting, and support to fit your clinic’s unique workflow, helping you stay efficient without compromising care quality.

This level of service leads to better outcomes for patients and less administrative burden for your staff.

Our UTI panel detects a broad spectrum of bacterial and fungal pathogens that are commonly associated with urinary tract infections. This includes both typical and atypical organisms, enhancing diagnostic accuracy in complex or recurrent cases.

UTI ID Results are typically available within 24 hours of receiving sample. The antibiotic resistance genes results are typically available within 48 hours of receiving sample. This rapid turnaround enables clinicians to make quick decisions regarding treatment, isolation, or follow-up care.

The test requires a clean-catch urine sample, which is non-invasive and easy to collect — especially important for elderly or debilitated patients.

Traditional cultures may take several days and can miss low-level infections or pathogens suppressed by prior antibiotics. Our PCR-based test offers:

• Higher sensitivity
• Faster detection
• Ability to identify organisms that culture might miss, especially in partially treated patients

Yes. The panel includes detection of resistance markers, such as genes associated with ESBLs, carbapenemases, and other resistance mechanisms. This helps clinicians choose the most effective therapy upfront.

The test is ideal for:

• Elderly and immunocompromised patients
• Residents in long-term care facilities
• Patients with recurrent or complicated UTIs
• Patients who are already on antibiotics but still symptomatic

Absolutely. By distinguishing between bacterial and non-bacterial causes, the test helps guide targeted therapy and reduces empirical or unnecessary antibiotic prescriptions, supporting antimicrobial stewardship.

Yes. Rapid identification allows for timely intervention, isolation, and infection control measures, helping to contain outbreaks — particularly in congregate care environments.

Yes. A healthcare provider's prescription or order is required to initiate testing and ensure proper interpretation of results.

LabTurbo offers:

• 24-hour turnaround for rapid action
• Superior sensitivity via molecular PCR
• Resistance gene detection for better-informed prescribing
• Personalized service with fast, responsive communication and support
• No administrative burden — we handle all insurance billing and logistics

Our STD panel detects the most clinically relevant sexually transmitted infections, including:

• Gonorrhea
• Chlamydia
• Mycoplasma Genitalium
• Trichomonas Vaginalis
• Herpes Simplex Virus 1 (HSV-1)
• Herpes Simplex Virus 2 (HSV-2)

Test results are typically delivered within 24 hours of receive sample, enabling quick diagnosis, counseling, and treatment planning.

The test uses a simple urine sample — no pelvic exam required. This approach reduces discomfort and makes testing more accessible.

As a molecular PCR-based test, it provides:

• High sensitivity and specificity
• Detection of low infection loads
• Accurate diagnosis in early-stage infections

This significantly reduces the risk of false negatives and unnecessary repeat testing.

This test is recommended for:

• Sexually active individuals with signs or symptoms of an STD (e.g., genital discharge, irritation, lesions, or pelvic pain)
• Individuals with a new or multiple sexual partners
• Pregnant women, as part of routine prenatal screening to prevent complications such as preterm labor or neonatal infection
• Patients undergoing evaluation for reproductive health concerns or fertility workups
• Individuals who have had unprotected sex or a known exposure to an STD

Yes. The panel is fully aligned with recommendations from CDC, ACOG, and USPSTF for screening in women aged 30–65, as well as for high-risk groups.

Faster results support:

• Quick counseling and treatment
• Reduced patient anxiety
• Fewer follow-up visits
• Improved patient retention and compliance

Yes. A provider's order or prescription is typically required to ensure appropriate medical evaluation, result interpretation, and documentation for insurance purposes.

Most commercial plans and Medicare cover STD testing when it is medically indicated. LabTurbo handles all billing and reporting, with no added cost or paperwork burden to your office.

LabTurbo delivers:

• 24-hour PCR turnaround
• Non-invasive urine-based collection
• Superior diagnostic accuracy
• Responsive, personalized support
• Seamless logistics with no administrative hassle for your staff

The RP panel detects a wide range of common and atypical respiratory pathogens, including:

• Viruses (COVID-19, Influenza A, Influenza B, RSV, rhinovirus/enterovirus, adenovirus, parainfluenza, seasonal coronavirus, metapneumovirus)
• Bacteria (Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae)

This broad coverage enables accurate diagnosis, even when symptoms are nonspecific or overlapping.

Results are delivered within 24 hours of receive sample, allowing for prompt diagnosis, treatment, and infection control measures.

The test requires a single nasopharyngeal swab, which allows comprehensive testing without the need for multiple sample collections.

Unlike rapid antigen tests that typically detect only one or two viruses (such as flu A/B or COVID-19), this Respiratory Pathogen PCR panel detects a wide range of viral, bacterial, and atypical pathogens — including RSV, parainfluenza, rhinovirus, adenovirus, and Mycoplasma pneumoniae.

In addition, PCR technology offers:

• Much higher sensitivity and specificity
• Detection of low viral or bacterial loads, even in early or mild infections
• Fewer false negatives compared to rapid tests

This broader and more accurate detection supports better clinical decisions, especially in high-risk or outbreak-prone environments.

This Respiratory Pathogen PCR test is suitable for a wide range of patients, including young children, pediatric patients, and older adults. It is especially useful when symptoms are non-specific or overlapping.

Clinical use cases include:

• Patients with fever, cough, nasal congestion, sore throat, or difficulty breathing
• Children with respiratory symptoms where rapid and accurate diagnosis is critical to prevent complications or unnecessary antibiotics
• Suspected outbreaks in schools, daycares, or long-term care facilities
• Elderly or immunocompromised patients, who may be more vulnerable to severe illness
• Cases where empiric treatment has failed, or where it's important to differentiate between viral and bacterial causes

Yes. The test:

• Differentiates viral from bacterial infections, helping reduce unnecessary antibiotic use
• Identifies specific pathogens that may require targeted therapy
• Aids in infection control decisions, including isolation or cohorting of residents

Absolutely. During a respiratory outbreak, this test helps:

• Quickly identify the causative pathogen(s)
• Implement isolation and control measures
• Report to public health authorities in compliance with local and federal guidelines

Yes. A healthcare provider’s prescription or order is required to ensure appropriate use and interpretation of the results and insurance documentation.

In most cases, insurance (including Medicare) covers testing when it is medically necessary. LabTurbo handles all billing, reporting, and logistics, with no administrative burden to your office.

LabTurbo offers:

• 24-hour PCR turnaround
• Broad pathogen detection in a single swab
• Responsive support and custom reporting
• Seamless logistics and no-cost implementation for your practice

This helps you deliver faster, more accurate care while keeping your facility protected from potential outbreaks.

The LabTurbo GI PCR panel identifies a wide spectrum of bacterial, viral, and parasitic pathogens responsible for infectious gastroenteritis. Below is the list of pathogens grouped by type and similarity:

Bacterial Pathogens

• Toxin-Producing Bacteria:
  • Clostridioides difficile (Toxin A/B)
  • Shiga-like toxin-producing Escherichia coli (STEC) – stx1, stx2
  • Escherichia coli O157 (a subset of STEC)
• Enteric E. coli Pathotypes:
  • Enterotoxigenic E. coli (ETEC) – lt, st
  • Enteropathogenic E. coli (EPEC)
  • Enteroaggregative E. coli (EAEC)
  • Enteroinvasive E. coli (EIEC) / Shigella spp.
• Common Foodborne and Zoonotic Bacteria:
  • Salmonella spp.
  • Campylobacter spp. (C. jejuni, C. coli, C. upsaliensis)
  • Yersinia enterocolitica
• Waterborne and Shellfish-Associated Bacteria:
  • Vibrio cholerae
  • Other non-cholera Vibrio spp.

Viral Pathogens

• Highly Contagious Viral Gastroenteritis Agents:
  • Norovirus GI/GII
  • Sapovirus (Genogroups I, II, IV, V)
• Pediatric and Institutional Outbreak Viruses:
  • Rotavirus A
  • Adenovirus F (Types 40/41)
  • Astrovirus

Parasitic Pathogens

• Protozoa Causing Acute Diarrhea:
  • Giardia lamblia (G. intestinalis / G. duodenalis)
  • Cryptosporidium spp.
  • Entamoeba histolytica
• Coccidian Parasite:
  • Cyclospora cayetanensis

This panel offers a comprehensive and rapid diagnostic solution for evaluating gastrointestinal symptoms — especially when the cause is unclear or multiple pathogens are suspected.

Results are typically available within 24 hours of receive sample, allowing providers to act quickly to start treatment, initiate isolation, or manage potential outbreaks.

A stool swab sample is used, which is easy to collect and less invasive than full stool specimens. This simplifies the process for both patients and healthcare staff.

Traditional stool tests — such as culture, antigen tests, or ova & parasite exams — have several key limitations:

• Longer turnaround times: Results can take several days, delaying treatment and infection control.
• Lower sensitivity: Cultures may miss low-level infections or pathogens suppressed by prior antibiotic use.
• Incomplete pathogen coverage:
  • Many routine cultures do not test for viral causes like norovirus or rotavirus.
  • Some also do not detect or distinguish between all strains of E. coli, Campylobacter, or other clinically significant bacteria.
  • Parasitic pathogens can also be missed or misidentified depending on lab technique.

In contrast, LabTurbo's GI PCR test offers:

• 24-hour turnaround
• High sensitivity and specificity
• Detection of bacteria, viruses, and parasites in one test
• Simultaneous identification of multiple pathogens, including co-infections

This makes it a more reliable and efficient tool for managing infectious diarrhea and outbreak situations.

This test is appropriate for:

• Patients with acute diarrhea, vomiting, abdominal pain, or fever
• Outbreak investigations in group living settings such as nursing homes, shelters, or daycares
• Patients at high risk for complications, including the elderly, immunocompromised, and very young children
• Situations where timely identification of the causative pathogen is critical for infection control and treatment

Yes. The test helps clinicians determine whether symptoms are due to viral, bacterial, or parasitic infections, which supports more targeted treatment and reduces unnecessary antibiotic use.

Yes — this test is especially valuable in managing outbreaks of infectious gastroenteritis in schools, daycares, long-term care facilities, and other group settings.

With 24-hour results and the ability to detect multiple pathogens at once, the test allows for:

• Early identification of the causative organism (e.g., norovirus, C. difficile, or Salmonella)
• Prompt isolation, cohorting, and sanitation measures
• Reporting to public health authorities to stay in compliance with local and federal guidelines

For pediatric settings, this test also gives parents peace of mind by confirming whether a child has a contagious or treatable GI infection — helping to determine if home care is sufficient or if escalated treatment is needed.

Yes. A healthcare provider’s order or prescription is required for testing, ensuring proper documentation, result interpretation, and treatment planning.

Most insurance providers, including Medicare, cover GI pathogen testing when it is medically indicated. LabTurbo handles all billing, logistics, and reporting, with no cost to your office.

LabTurbo offers:

• 24-hour turnaround
• Broad detection of bacteria, viruses, and parasites
• Easy specimen collection
• Responsive support and personalized logistics
• No administrative burden to your staff

This makes it an ideal solution for rapid diagnosis and infection control, especially in settings with vulnerable populations.

The LabTurbo Pneumonia Panel detects a wide range of bacterial, viral, and fungal pathogens associated with lower respiratory tract infections. It also includes detection of select antimicrobial resistance genes, such as mecA/mecC (MRSA markers), helping guide targeted antibiotic therapy.

Results are available within 24 hours of receive sample, providing actionable data to initiate timely treatment, isolation, or outbreak response without delay.

The test uses a single sputum sample (collected by the patient spitting into a sterile cup), making it non-invasive and easier to obtain than bronchoscopic or lavage samples.

Traditional methods can take 48–72 hours, may be affected by prior antibiotic use, and often fail to detect low-abundance or fastidious organisms.

In contrast, the LabTurbo PCR panel offers:

• Rapid, highly sensitive results
• Detection of low viral or bacterial loads
• Simultaneous testing for multiple pathogens and resistance markers
• Coverage of both community- and healthcare-associated organisms

This test is ideal for:

• Patients presenting with cough, fever, shortness of breath, chest pain, or abnormal imaging
• Elderly and immunocompromised individuals at higher risk for pneumonia complications
• Cases of suspected healthcare-associated pneumonia (HCAP) or ventilator-associated pneumonia (VAP)
• Situations requiring differentiation between viral and bacterial causes to guide antibiotic stewardship

Yes. By identifying the specific pathogen and any antibiotic resistance markers, this test helps:

• Guide targeted antimicrobial therapy
• Avoid unnecessary or broad-spectrum antibiotic use
• Reduce the risk of antimicrobial resistance

Absolutely. In long-term care facilities, nursing homes, and hospital wards, the test supports:

• Rapid identification of causative agents
• Isolation of infected individuals
• Outbreak containment and notification to public health authorities
• Helps clinicians differentiate between infectious and non-infectious respiratory symptoms, reducing unnecessary treatments or transfers.

Yes. This test is particularly valuable in young children, older adults, and immunocompromised individuals, where:

• Infections may progress quickly
• Symptoms may be atypical
• Early, accurate treatment can reduce complications and hospitalizations

Yes. A provider’s prescription or order is required to initiate testing and ensure appropriate clinical follow-up and insurance documentation.

LabTurbo offers:

• 24-hour turnaround
• Detection of multiple pathogens and resistance genes
• Simple sputum-based collection
• High sensitivity with PCR technology
• Responsive and customizable support, plus insurance billing included — with no added burden to your practice

The LabTurbo HPV test detects the two most clinically significant high-risk genotypes:

• HPV-16
• HPV-18

These two strains are responsible for the majority of cervical cancer cases and are key targets in screening and early intervention.

This test is used for risk stratification in women aged 30–65, typically as part of:

• Primary HPV screening
• Co-testing with Pap smear (cytology)
• Follow-up for previously abnormal cytology results

Early identification of high-risk HPV types allows for earlier monitoring, prevention, and treatment before cellular abnormalities occur.

Using real-time PCR technology, this test provides:

• Superior sensitivity and specificity
• Detection of low viral loads
• Accurate results in early infections

This reduces the risk of false negatives and supports timely clinical decisions.

Results are typically available in 24 hours of receive sample, enabling quick counseling and follow-up planning when needed.

A cervical swab collected during a routine pelvic exam is used. This can be done alone or alongside a Pap smear using the same sample collection.

This test is recommended for:

• Women aged 30 to 65 as part of routine HPV screening or co-testing
• Patients with previous abnormal Pap results
• Individuals undergoing cervical cancer screening per CDC, ACOG, and USPSTF guidelines

Not necessarily. The HPV test can be used alone (primary screening) or in combination with the Pap smear (co-testing). Many practices now use HPV-first screening to identify high-risk patients before cytologic changes appear.

Yes. It can be used to:

• Track persistence of high-risk HPV types
• Monitor for clearance or progression
• Support decisions about colposcopy or follow-up intervals

Yes. A healthcare provider’s order or prescription is required to initiate testing and to ensure the results are appropriately interpreted and followed up.

LabTurbo provides:

• Fast 24-hour PCR results
• High analytical sensitivity
• Seamless integration with cervical cancer screening workflows
• Compliance with national screening guidelines
• Responsive client support and no administrative burden — we manage all supplies, reporting, and insurance billing